02 / 04 · A research career takes shape
From biotechnology to genomics
An eight-year Senior Director tenure at Affymetrix followed earlier scientific roles at Chiron and Millennium Pharmaceuticals.
← Back to the career genomeA sourced chapter
The work in context.
Veracyte’s SEC-filed biography documents Kennedy as a Senior Director at Affymetrix from January 2000 through March 2008. It also names earlier scientific roles at Chiron Corporation and Millennium Pharmaceuticals, without titles or dates. Those earlier roles are context rather than separately dated milestones.
How did an Affymetrix Senior Director role sit within an earlier biotechnology career?
What the evidence can say
The boundary matters.
Chiron and Millennium roles are directly named, but their titles and chronology are not. No project outcome is claimed for the Affymetrix tenure.
Documented relationships
People & institutions on record
A line here means a recorded role, training or publication affiliation. It does not infer a permanent team or employment from coauthorship.
- Scientific or company roleGiulia C. KennedyChiron Corporation
Scientific role (title not documented) · Before Affymetrix; relative order with Millennium not established
View record - Scientific or company roleGiulia C. KennedyMillennium Pharmaceuticals
Scientific role (title not documented) · Before Affymetrix; relative order with Chiron not established
View record - Scientific or company roleGiulia C. KennedyAffymetrix
Senior Director
View record
Chapter sources
Evidence is linked to its original record. Dates and interpretations are qualified in the chapter text.
- Veracyte 2022 definitive proxy statement U.S. SEC / Veracyte · 2022-04-26
- Veracyte Form S-1 registration statement U.S. SEC / Veracyte · 2013-09-20